• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后妇女骨质疏松性骨折的预测因素:荟萃分析。

Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis.

机构信息

Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning, 530021, Guangxi, China.

出版信息

J Orthop Surg Res. 2023 Aug 5;18(1):574. doi: 10.1186/s13018-023-04051-6.

DOI:10.1186/s13018-023-04051-6
PMID:37543616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10404374/
Abstract

Osteoporosis affects more than 200 million women worldwide, with postmenopausal women being particularly susceptible to this condition and its severe sequelae disproportionately, such as osteoporotic fractures. To date, the current focus has been more on symptomatic treatment, rather than preventive measures. To address this, we performed a meta-analysis aiming to identify potential predictors of osteoporotic fractures in postmenopausal women, with the ultimate goal of identifying high-risk patients and exploring potential therapeutic approaches. We searched Embase, MEDLINE and Cochrane with search terms (postmenopausal AND fracture) AND ("risk factor" OR "predictive factor") in May 2022 for cohort and case-control studies on the predictors of osteoporotic fracture in postmenopausal women. Ten studies with 1,287,021 postmenopausal women were found eligible for analyses, in which the sample size ranged from 311 to 1,272,115. The surveyed date spanned from 1993 to 2021. Our results suggested that age, BMI, senior high school and above, parity ≥ 3, history of hypertension, history of diabetes mellitus, history of alcohol intake, age at menarche ≥ 15, age at menopause < 40, age at menopause > 50, estrogen use and vitamin D supplements were significantly associated with osteoporotic fracture in postmenopausal women. Our findings facilitate the early prediction of osteoporotic fracture in postmenopausal women and may contribute to potential therapeutic approaches. By focusing on preventive strategies and identifying high-risk individuals, we can work toward reducing the burden of osteoporosis-related fractures in this vulnerable population.

摘要

骨质疏松症影响着全球超过 2 亿的女性,其中绝经后女性尤其容易受到这种疾病及其严重后果的影响,例如骨质疏松性骨折。迄今为止,当前的重点更多地放在症状治疗上,而不是预防措施上。为了解决这个问题,我们进行了一项荟萃分析,旨在确定绝经后妇女骨质疏松性骨折的潜在预测因素,最终目的是确定高危患者并探索潜在的治疗方法。我们于 2022 年 5 月在 Embase、MEDLINE 和 Cochrane 中使用了(绝经后 AND 骨折)和(“风险因素”或“预测因素”)搜索词,以寻找关于绝经后妇女骨质疏松性骨折预测因素的队列和病例对照研究。我们发现了 10 项符合条件的研究,其中有 1287021 名绝经后女性符合分析条件,样本量从 311 到 1272115 不等。调查的日期从 1993 年到 2021 年不等。我们的研究结果表明,年龄、BMI、高中及以上学历、产次≥3、高血压病史、糖尿病病史、饮酒史、初潮年龄≥15 岁、绝经年龄<40 岁、绝经年龄>50 岁、雌激素使用和维生素 D 补充剂与绝经后妇女的骨质疏松性骨折显著相关。我们的发现有助于绝经后妇女骨质疏松性骨折的早期预测,并可能有助于潜在的治疗方法。通过关注预防策略和确定高危个体,我们可以努力减少这一脆弱人群中与骨质疏松相关的骨折负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1734/10404374/ef7799b361fd/13018_2023_4051_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1734/10404374/ef7799b361fd/13018_2023_4051_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1734/10404374/ef7799b361fd/13018_2023_4051_Fig1_HTML.jpg

相似文献

1
Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis.绝经后妇女骨质疏松性骨折的预测因素:荟萃分析。
J Orthop Surg Res. 2023 Aug 5;18(1):574. doi: 10.1186/s13018-023-04051-6.
2
Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?绝经后女性骨折风险的人群筛查——减轻骨质疏松性骨折负担的合理举措?
Osteoporos Int. 2022 Aug;33(8):1631-1637. doi: 10.1007/s00198-022-06419-6. Epub 2022 Jun 28.
3
Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures.亚洲-太平洋地区绝经后妇女低骨量或骨质疏松症但无脆性骨折的骨质疏松性骨折预防共识。
J Formos Med Assoc. 2023;122 Suppl 1:S14-S20. doi: 10.1016/j.jfma.2023.01.013. Epub 2023 Feb 10.
4
Associations of Age at Menopause With Postmenopausal Bone Mineral Density and Fracture Risk in Women.绝经年龄与女性绝经后骨密度和骨折风险的关系。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e561-e569. doi: 10.1210/clinem/dgab690.
5
Obesity and fractures in postmenopausal women.绝经后女性的肥胖与骨折
Curr Opin Rheumatol. 2015 Jul;27(4):414-9. doi: 10.1097/BOR.0000000000000182.
6
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study.根据国家骨骼健康联盟(NBHA)诊断标准评估意大利绝经后女性骨质疏松症的流行病学:一项多中心队列研究。
J Endocrinol Invest. 2018 Apr;41(4):431-438. doi: 10.1007/s40618-017-0761-4. Epub 2017 Sep 27.
7
Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.依发洛肽对 FRAX 概率评估骨折风险增高的绝经后妇女亚组的椎体、非椎体、主要骨质疏松性和临床骨折的影响。
Arch Osteoporos. 2019 Feb 5;14(1):15. doi: 10.1007/s11657-019-0564-7.
8
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women.绝经后早期和晚期女性发生骨质疏松性骨折的不同饮食风险因素。
J Bone Miner Metab. 2023 Mar;41(2):227-238. doi: 10.1007/s00774-023-01400-7. Epub 2023 Jan 30.
9
The proportion of Thai postmenopausal women who would be eligible for anti-osteoporosis therapy.适合接受骨质疏松症治疗的泰国绝经后女性的比例。
PLoS One. 2023 Feb 3;18(2):e0279829. doi: 10.1371/journal.pone.0279829. eCollection 2023.
10
Denosumab versus Bisphosphonates for Reducing Fractures in Postmenopausal Women with Osteoporosis: A Meta-Analysis.地舒单抗与双膦酸盐类药物治疗绝经后骨质疏松症妇女骨折的疗效比较:一项荟萃分析。
J Am Board Fam Med. 2023 Feb 8;36(1):175-185. doi: 10.3122/jabfm.2022.220099R1. Epub 2023 Jan 18.

引用本文的文献

1
Toward Sex-Specific Biomaterials Innovation: A Perspective.迈向性别特异性生物材料创新:一种观点。
ACS Biomater Sci Eng. 2025 Sep 8;11(9):5131-5144. doi: 10.1021/acsbiomaterials.5c00342. Epub 2025 Aug 20.
2
The diagnostic and therapeutic potential of miR-3149 in osteoporotic fractures through SMAD4.通过SMAD4研究miR-3149在骨质疏松性骨折中的诊断和治疗潜力。
J Orthop Surg Res. 2025 Aug 19;20(1):773. doi: 10.1186/s13018-025-06182-4.
3
MiR-23a-5p affects postmenopausal osteoporosis by targeting ALX3 to regulate osteoblast differentiation.

本文引用的文献

1
Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis.抗吸收药物治疗皮质类固醇性骨质疏松症:贝叶斯网状meta 分析。
Br Med Bull. 2022 Sep 22;143(1):46-56. doi: 10.1093/bmb/ldac017.
2
Fragility Fractures: Risk Factors and Management in the Elderly.脆性骨折:老年人的风险因素与管理。
Medicina (Kaunas). 2021 Oct 17;57(10):1119. doi: 10.3390/medicina57101119.
3
Incidence of fractures in women in the post-menopause: a cohort study in primary care in southern Brazil.绝经后女性骨折的发生率:巴西南部初级保健中的队列研究。
微小RNA-23a-5p通过靶向ALX3调控成骨细胞分化来影响绝经后骨质疏松症。
J Orthop Surg Res. 2025 Jul 25;20(1):700. doi: 10.1186/s13018-025-06133-z.
4
Association of reproductive characteristics with osteoporosis and FRAX scores in Chinese postmenopausal women: a QCT-based cross-sectional study.中国绝经后女性生殖特征与骨质疏松症及FRAX评分的关联:一项基于定量CT的横断面研究
Sci Rep. 2025 Jul 10;15(1):24937. doi: 10.1038/s41598-025-09387-z.
5
Utilizing MRI and CT to identify risk factors associated with cage subsidence.利用磁共振成像(MRI)和计算机断层扫描(CT)来识别与椎间融合器下沉相关的风险因素。
Eur J Med Res. 2025 Jul 1;30(1):529. doi: 10.1186/s40001-025-02797-9.
6
The Association of rs17166249 and rs412777 Polymorphisms on the Bone Mineral Density in Polish Postmenopausal Women.rs17166249和rs412777多态性与波兰绝经后女性骨密度的关联
Biomolecules. 2025 May 27;15(6):775. doi: 10.3390/biom15060775.
7
Global burden of vertebral fractures from 1990 to 2021 and projections for the next three decades.1990年至2021年椎体骨折的全球负担及未来三十年的预测。
J Orthop Surg Res. 2025 May 17;20(1):480. doi: 10.1186/s13018-025-05915-9.
8
Top comorbidities in osteoporotic fracture patients in a northeast population in China.中国东北地区骨质疏松性骨折患者的主要合并症
BMC Public Health. 2025 May 2;25(1):1640. doi: 10.1186/s12889-025-22331-0.
9
Preliminary Exploration of the Osteogenic Differentiation Mechanism of Bone Marrow Mesenchymal Stem Cells Regulated by SYVN1.SYVN1调控骨髓间充质干细胞成骨分化机制的初步探索
J Musculoskelet Neuronal Interact. 2025 Mar 1;25(1):150-159. doi: 10.22540/JMNI-25-150.
10
A comprehensive analysis and performance evaluation for osteoporosis prediction models.骨质疏松症预测模型的综合分析与性能评估
PeerJ Comput Sci. 2024 Dec 4;10:e2338. doi: 10.7717/peerj-cs.2338. eCollection 2024.
Arch Osteoporos. 2021 Sep 7;16(1):126. doi: 10.1007/s11657-021-00972-z.
4
Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis.药物对绝经后骨质疏松症患者骨密度的影响:贝叶斯网状Meta 分析。
J Orthop Surg Res. 2021 Aug 27;16(1):533. doi: 10.1186/s13018-021-02678-x.
5
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study.中国骨质疏松症患病率及骨折患病情况:中国骨质疏松症流行病学调查。
JAMA Netw Open. 2021 Aug 2;4(8):e2121106. doi: 10.1001/jamanetworkopen.2021.21106.
6
Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review.绝经后骨质疏松症药物治疗中生物标志物的潜力:系统评价。
J Orthop Surg Res. 2021 May 31;16(1):351. doi: 10.1186/s13018-021-02497-0.
7
Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review.作为绝经后骨质疏松症治疗监测的生物标志物:系统评价。
J Orthop Surg Res. 2021 May 18;16(1):318. doi: 10.1186/s13018-021-02474-7.
8
Physical Activity and Bone Health in Men: A Systematic Review and Meta-Analysis.男性的身体活动与骨骼健康:一项系统评价与荟萃分析
J Bone Metab. 2021 Feb;28(1):27-39. doi: 10.11005/jbm.2021.28.1.27. Epub 2021 Feb 28.
9
Lower bone mineral density and higher bone resorption marker levels in premenopausal women with type 1 diabetes in Japan.日本 1 型糖尿病绝经前女性的骨矿物质密度较低,骨吸收标志物水平较高。
J Diabetes Investig. 2021 Sep;12(9):1689-1696. doi: 10.1111/jdi.13530. Epub 2021 Apr 3.
10
Plasma periostin as a biomarker of osteoporosis in postmenopausal women with type 2 diabetes.绝经后 2 型糖尿病女性中,血浆骨膜蛋白作为骨质疏松的生物标志物。
J Bone Miner Metab. 2021 Jul;39(4):631-638. doi: 10.1007/s00774-020-01200-3. Epub 2021 Feb 10.